scholarly journals The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention

2018 ◽  
Vol 100 (3) ◽  
pp. 271-278 ◽  
Author(s):  
Jennifer Kranz ◽  
Stefanie Schmidt ◽  
Cordula Lebert ◽  
Laila Schneidewind ◽  
Falitsa Mandraka ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Clinical Guideline ◽  
Adult Patients ◽  
Tract Infections

scholarly journals The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients: Part 1

2018 ◽  
Vol 100 (3) ◽  
pp. 263-270 ◽  
Author(s):  
Jennifer Kranz ◽  
Stefanie Schmidt ◽  
Cordula Lebert ◽  
Laila Schneidewind ◽  
Falitsa Mandraka ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Clinical Guideline ◽  
Adult Patients ◽  
Tract Infections

Management of Bacterial Urinary Tract Infections in Adult Patients with Diabetes Mellitus

Drugs ◽  
2002 ◽  
Vol 62 (13) ◽  
pp. 1859-1868 ◽  
Author(s):  
Ruby Meiland ◽  
Suzanne E. Geerlings ◽  
Andy I.M. Hoepelman
Keyword(s):  
Diabetes Mellitus ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Adult Patients ◽  
Patients With Diabetes ◽  
Tract Infections

Changes in Antimicrobial Resistance of Urinary Tract Infections in Adult Patients over a 5-Year Period

2020 ◽  
Vol 104 (3-4) ◽  
pp. 287-292
Author(s):  
Hulya Caskurlu ◽  
Meftun Culpan ◽  
Bulent Erol ◽  
Turgay Turan ◽  
Haluk Vahaboglu ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Antimicrobial Resistance ◽  
Urinary Tract Infections ◽  
Adult Patients ◽  
Tract Infections

scholarly journals Impact of a smartphone app on prescriber adherence to antibiotic guidelines in adult patients with community acquired pneumonia or urinary tract infections

PLoS ONE ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. e0211157 ◽  
Author(s):  
Chang Ho Yoon ◽  
Stephen R. Ritchie ◽  
Eamon J. Duffy ◽  
Mark G. Thomas ◽  
Stephen McBride ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Community Acquired Pneumonia ◽  
Adult Patients ◽  
Smartphone App ◽  
Tract Infections

Clean Intermittent Self-Catheterization in the Treatment of Urinary Tract Disease

2021 ◽  
pp. 281-286
Author(s):  
Jeffrey I. Estrin ◽  
Sean P. Elliott
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Case Series ◽  
Adult Patients ◽  
Safety And Efficacy ◽  
Happy Life ◽  
Bladder Emptying ◽  
Tract Disease ◽  
Tract Infections ◽  
Incomplete Bladder Emptying

This chapter summarizes the landmark experience of introducing clean intermittent catherization in a small case series of pediatric and adult patients with incomplete bladder emptying due to various etiologies. Patients were taught to self-catheterize themselves after having washed their hands, or their mothers were instructed to do so. All adult patients reported that control of their urinary difficulties helped them return to “live a normal, happy life.” The pediatric patients remained afebrile and continent, without urinary tract infections during the study period. Most adult patients also remained free from urinary tract infections during the study period. This study demonstrated the safety and efficacy of a clean, non-sterile approach to intermittent catheterization.

scholarly journals 1460. The Effectiveness of Short vs. Long Antibiotic Therapy in Hospitalized Adult Patients with Urinary Tract Infections: A Systematic Review and Meta-Analysis

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S533-S534
Author(s):  
Tala Ballouz ◽  
Nesrine Rizk
Keyword(s):  
Systematic Review ◽  
Drug Resistance ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Clinical Success ◽  
Meta Analysis ◽  
Adult Patients ◽  
Multi Drug Resistance ◽  
Trial Quality ◽  
Tract Infections

Abstract Background Urinary tract infections (UTIs) are a frequent cause of morbidity and mortality in hospitalized patients, if not adequately and promptly treated. The optimal treatment duration is controversial and most recommendations are based on clinical experience. Current guidelines recommend 5–14 days of treatment depending on the type and severity of infection and the antibiotic used. With the emergence of multi-drug resistance, shorter durations are increasingly favored. This systematic review of randomized controlled trials (RCTs) aims at providing updated evidence on the effectiveness of short (≤7 days) vs. long (>7 days) antibiotic regimens in hospitalized adult patients. Methods MEDLINE, EMBASE, and CENTRAL were searched to identify relevant RCTs. Trial quality was evaluated using Cochrane’s Risk of Bias Tool. The primary outcome was clinical success. Secondary outcomes included microbiological success, withdrawal due to adverse events (AE), relapse, and reinfection rates. A random-effect meta-analysis was performed using R. Results 8 RCTs conducted between 1995 and 2018 were identified. Trial quality was considered poor in 5, fair in 1 and good in 2 RCTs. Clinical and microbiological success was reported in all studies. Withdrawal due to AE was reported in 5, relapse and reinfection in 3 studies. Overall, there was no difference in clinical success between short and long courses (OR = 0.92, 95% CI 0.66–1.29; 2111 patients) (figure). Similarly, microbiological success was comparable in the two arms (OR = 1.0, 95% CI 0.70–1.43; 2111 patients). There was a higher, but nonsignificant, number of withdrawals due to AE in the long duration arm (OR = 0.78, 95% CI 0.29–2.11; 1890 patients). Patients receiving short courses had a nonsignificant higher rate of relapse (OR = 2.65, 95% CI 0.31–22.39, 175 patients). However, there was no difference in reinfection rates (OR = 1.12, 95% CI 0.26–4.90; 175 patients). A subgroup analysis limited to complicated UTIs showed similar results. Conclusion Based on the limited available evidence, short antibiotic courses appear to be equally effective as longer courses in the management of inpatient UTIs. Further research is needed to determine appropriate antibiotic treatment durations and assess treatment-related development of drug resistance. Disclosures All authors: No reported disclosures.

Sign in / Sign up

Export Citation Format

Share Document